Shareholders approve 400,000-share increase to GRI Bio's 2018 Equity Incentive Plan

GRI Bio, Inc.

Shareholders voted 48,362 to 17,889 (179 abstain) to approve the amendment; broker non-votes: 1,023,943.
Plan increase: 400,000 additional shares of common stock reserved for issuance under the Amended and Restated 2018 Equity Incentive Plan.
Approximately 43.67% quorum (1,090,373 of 2,496,800 eligible shares) was present at the virtual August 13, 2025 Annual Meeting.
Directors Roelof Rongen and Camilla V. Simpson elected with 63,031 and 63,581 votes for, respectively (broker non-votes: 1,023,943 each).
Ratification of WithumSmith+Brown as auditor: 1,072,167 for, 16,553 against, 1,653 abstain (no broker non-votes).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.